Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 12-2018 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 138,807 | 518,100 | 449,200 | 446,200 |
| Marketable Securities | 0 | 0 | 178,800 | 181,000 | 111,300 |
| Receivables | 0 | 192 | 252,500 | 223,900 | 210,500 |
| Inventories | 0 | 0 | 106,400 | 116,300 | 122,800 |
| Other current assets | 0 | 3,081 | 0 | 0 | 0 |
| TOTAL | $0 | $142,080 | $1,107,700 | $1,007,000 | $929,600 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 146,500 | 147,900 | 153,800 |
| Investments And Advances | 0 | 0 | 0 | 85,300 | 79,200 |
| Intangibles | 0 | 0 | 81,900 | 85,400 | 89,800 |
| Other Non-Current Assets | 0 | 6,938 | 138,400 | 89,400 | 92,700 |
| TOTAL | $N/A | $6,938 | $366,800 | $408,000 | $415,500 |
| Total Assets | $0 | $150,558 | $1,474,500 | $1,415,000 | $1,345,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | N/A | 300 | 300 |
| Accounts payable and accrued liabilities | 0 | 6,750 | 97,200 | 82,200 | 77,300 |
| Accrued Expenses | 0 | 13,650 | 111,100 | 89,500 | 92,000 |
| Other current liabilities | 0 | 1,765 | N/A | N/A | N/A |
| TOTAL | $0 | $22,354 | $288,700 | $255,900 | $251,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 650,800 | 650,900 | 650,900 |
| Other Non-Current Liabilities | 0 | 1,961 | 99,800 | 78,900 | 86,600 |
| TOTAL | $N/A | $1,961 | $751,400 | $729,700 | $737,900 |
| Total Liabilities | $0 | $24,315 | $1,040,100 | $985,600 | $989,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 97,156 | 97,031 | 96,989 |
| Common Shares | 0 | 401 | 23,700 | N/A | N/A |
| Retained earnings | 0 | -332,085 | -898,400 | N/A | N/A |
| Other shareholders' equity | 0 | 5,659 | -15,200 | 429,400 | 355,300 |
| TOTAL | $0 | $126,243 | $434,400 | $429,400 | $355,300 |
| Total Liabilities And Equity | $0 | $150,558 | $1,474,500 | $1,415,000 | $1,345,100 |